As of April 2024 Allogene Therapeutics has a market cap of $0.58 Billion. This makes Allogene Therapeutics the world's 5750th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.
Year | Market cap | Change |
---|---|---|
2024 | $0.58 B | 8.62% |
2023 | $0.54 B | -40.45% |
2022 | $0.90 B | -57.34% |
2021 | $2.12 B | -39.95% |
2020 | $3.54 B | 11.8% |
2019 | $3.16 B | -3.19% |
2018 | $3.27 B |
On Apr 19th, 2024 the market cap of Allogene Therapeutics was reported to be:
Name | Market cap | Market cap differencediff. | Country |
---|---|---|---|
ORIC Pharmaceuticals
ORIC | $0.61 B | 5.53% | ๐บ๐ธ USA |